https://orcid.org/0000-0002-6462-5101
Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Shiza Malik, Khalid Muhammad, Sanaa Masood Aslam & Yasir Waheed. (2023) Tracing the recent updates on vaccination approaches and significant adjuvants being developed against HIV. Expert Review of Anti-infective Therapy 21:4, pages 431-446.
Read now
Read now
Shengtao Fan, Kang Xiao, Dandan Li, Heng Zhao, Jingjing Zhang, Li Yu, Penglan Chang, Shuangli Zhu, Xingli Xu, Yun Liao, Tianjiao Ji, Guorun Jiang, Dongmei Yan, Fengyuan Zeng, Suqin Duan, Baicheng Xia, Lichun Wang, Fengmei Yang, Zhanlong He, Yang Song, Pingfang Cui, Xiaolei Li, Yaxing Zhang, Bangyi Zheng, Ying Zhang, Wenbo Xu & Qihan Li. (2022) Preclinical immunological evaluation of an intradermal heterologous vaccine against SARS-CoV-2 variants. Emerging Microbes & Infections 11:1, pages 212-226.
Read now
Read now
Christopher P. Karch & Gary R. Matyas. (2021) The current and future role of nanovaccines in HIV-1 vaccine development. Expert Review of Vaccines 20:8, pages 935-944.
Read now
Read now
Jialu Zhang, Qian He, Chaoqiang An, Qunying Mao, Fan Gao, Lianlian Bian, Xing Wu, Qian Wang, Pei Liu, Lifang Song, Yaqian Huo, Siyuan Liu, Xujia Yan, Jinghuan Yang, Bopei Cui, Changgui Li, Junzhi Wang, Zhenglun Liang & Miao Xu. (2021) Boosting with heterologous vaccines effectively improves protective immune responses of the inactivated SARS-CoV-2 vaccine. Emerging Microbes & Infections 10:1, pages 1598-1608.
Read now
Read now
Qian He, Qunying Mao, Chaoqiang An, Jialu Zhang, Fan Gao, Lianlian Bian, Changgui Li, Zhenglun Liang, Miao Xu & Junzhi Wang. (2021) Heterologous prime-boost: breaking the protective immune response bottleneck of COVID-19 vaccine candidates. Emerging Microbes & Infections 10:1, pages 629-637.
Read now
Read now
Articles from other publishers (25)
Alireza Milani, Elahe Akbari, Parisa Moradi Pordanjani, Fateme Jamshidi, Shahrzad Ghayoumi, Seyed Amir Sadeghi & Azam Bolhassani. (2023)
Immunostimulatory effects of Hsp70 fragments and Hsp27 in design of novel
HIV
‐1 vaccine formulations
. HIV Medicine.
Crossref
Crossref
Dominik Damm, Ehsan Suleiman, Jannik T. Wagner, Stephan Klessing, Felix Pfister, Hassan Elsayed, Bernd Walkenfort, Jule Stobrawe, Julia Mayer, Elisabeth Lehner, Sandra M. Müller-Schmucker, Mike Hasenberg, Richard T. Wyatt, Karola Vorauer-Uhl, Vladimir Temchura & Klaus Überla. (2023) Modulation of immune responses to liposomal vaccines by intrastructural help. European Journal of Pharmaceutics and Biopharmaceutics 192, pages 112-125.
Crossref
Crossref
Ferran Tarrés-Freixas, Carmen Aguilar-Gurrieri, María Luisa Rodríguez de la Concepción, Victor Urrea, Benjamin Trinité, Raquel Ortiz, Edwards Pradenas, Pau Blanco, Sílvia Marfil, Luis Manuel Molinos-Albert, Ana Barajas, Anna Pons-Grífols, Carlos Ávila-Nieto, Ismael Varela, Laura Cervera, Sònia Gutiérrez-Granados, María Mercedes Segura, Francesc Gòdia, Bonaventura Clotet, Jorge Carrillo & Julià Blanco. (2023) An engineered HIV-1 Gag-based VLP displaying high antigen density induces strong antibody-dependent functional immune responses. npj Vaccines 8:1.
Crossref
Crossref
Beibei Zhang, Hongyan Mao, Hongjuan Zhu, Jingxia Guo, Paul Zhou & Zhenghai Ma. (2023) Response to HIV-1 gp160-carrying recombinant virus HSV-1 and HIV-1 VLP combined vaccine in BALB/c mice. Frontiers in Microbiology 14.
Crossref
Crossref
Alireza Milani, Elnaz Agi, Mohammad Hassan Pouriayevali, Mahdieh Motamedi-Rad, Fatemeh Motevalli & Azam Bolhassani. (2022) Different dendritic cells-based vaccine constructs influence HIV-1 antigen-specific immunological responses and cytokine generation in virion-exposed splenocytes. International Immunopharmacology 113, pages 109406.
Crossref
Crossref
Jialu Zhang, Qian He, Xujia Yan, Jianyang Liu, Yu Bai, Chaoqiang An, Bopei Cui, Fan Gao, Qunying Mao, Junzhi Wang, Miao Xu & Zhenglun Liang. (2022) Mixed formulation of mRNA and protein‐based COVID‐19 vaccines triggered superior neutralizing antibody responses. MedComm 3:4.
Crossref
Crossref
Phindile Ximba, Rosamund Chapman, Ann Meyers, Emmanuel Margolin, Michiel T van Diepen, Adam F Sander, Jeremy Woodward, Penny L Moore, Anna-Lise Williamson & Edward P Rybicki. (2022) Development of a synthetic nanoparticle vaccine presenting the HIV-1 envelope glycoprotein. Nanotechnology 33:48, pages 485102.
Crossref
Crossref
Chen Zhang, Peng-Qi Zhang, Sheng Guo, Zhao Zhao, Gao-Xue Wang & Bin Zhu. (2022) Dual-Targeting Polymer Nanoparticles Efficiently Deliver DNA Vaccine and Induce Robust Prophylactic Immunity against Spring Viremia of Carp Virus Infection. Microbiology Spectrum 10:5.
Crossref
Crossref
Qian He, Qunying Mao, Jialu Zhang, Fan Gao, Yu Bai, Bopei Cui, Jianyang Liu, Chaoqiang An, Qian Wang, Xujia Yan, Jinghuan Yang, Lifang Song, Ziyang Song, Dong Liu, Yadi Yuan, Jing Sun, Jincun Zhao, Lianlian Bian, Xing Wu, Weijin Huang, Changgui Li, Junzhi Wang, Zhenglun Liang & Miao Xu. (2022) Heterologous immunization with adenovirus vectored and inactivated vaccines effectively protects against SARS-CoV-2 variants in mice and macaques. Frontiers in Immunology 13.
Crossref
Crossref
Naina McCann, Daniel O’Connor, Teresa Lambe & Andrew J Pollard. (2022) Viral vector vaccines. Current Opinion in Immunology 77, pages 102210.
Crossref
Crossref
Laura Richert, Jean-Daniel Lelièvre, Christine Lacabaratz, Lucile Hardel, Hakim Hocini, Aurélie Wiedemann, Frédéric Lucht, Isabelle Poizot-Martin, Claire Bauduin, Alpha Diallo, Véronique Rieux, Elodie Rouch, Mathieu Surenaud, Cécile Lefebvre, Emile Foucat, Pascaline Tisserand, Lydia Guillaumat, Mélany Durand, Boris Hejblum, Odile Launay, Rodolphe Thiébaut & Yves Lévy. (2022) T Cell Immunogenicity, Gene Expression Profile, and Safety of Four Heterologous Prime-Boost Combinations of HIV Vaccine Candidates in Healthy Volunteers: Results of the Randomized Multi-Arm Phase I/II ANRS VRI01 Trial. The Journal of Immunology 208:12, pages 2663-2674.
Crossref
Crossref
Zoltán Bánki, Jose Mateus, Annika Rössler, Helena Schäfer, David Bante, Lydia Riepler, Alba Grifoni, Alessandro Sette, Viviana Simon, Barbara Falkensammer, Hanno Ulmer, Bianca Neurauter, Wegene Borena, Florian Krammer, Dorothee von Laer, Daniela Weiskopf, Janine Kimpel, Petra Flatscher, Lukas Forer, Elisabeth Graf, Gerhard Hausberger, Peter Heininger, Michael Kundi, Christine Mantinger, Conny Ower, Daniel Rainer, Magdalena Sacher, Lisa Seekircher, Sebastian Schönherr, Marton Szell, Tobias Trips, Ursula Wiedermann, Peter Willeit, Reinhard Würzner & August Zabernigg. (2022) Heterologous ChAdOx1/BNT162b2 vaccination induces stronger immune response than homologous ChAdOx1 vaccination: The pragmatic, multi-center, three-arm, partially randomized HEVACC trial. eBioMedicine 80, pages 104073.
Crossref
Crossref
Laury-Anne Leroy, Alice Mac Donald, Aditi Kandlur, Deepanwita Bose, Peng Xiao, Jean Gagnon, François Villinger & Yahia Chebloune. (2022) Cytokine Adjuvants IL-7 and IL-15 Improve Humoral Responses of a SHIV LentiDNA Vaccine in Animal Models. Vaccines 10:3, pages 461.
Crossref
Crossref
Shixia Wang, Nicole L. Yates, Justin Pollara, Yegor Voronin, Sherry Stanfield-Oakley, Dong Han, Guangnan Hu, Wei Li, Guido Ferrari, Georgia D. Tomaras & Shan Lu. (2022) Broadly binding and functional antibodies and persisting memory B cells elicited by HIV vaccine PDPHV. npj Vaccines 7:1.
Crossref
Crossref
Jingxin Li, Lihua Hou, Xiling Guo, Pengfei Jin, Shipo Wu, Jiahong Zhu, Hongxing Pan, Xue Wang, Zhizhou Song, Jingxuan Wan, Lunbiao Cui, Junqiang Li, Yin Chen, Xuewen Wang, Lairun Jin, Jingxian Liu, Fengjuan Shi, Xiaoyu Xu, Tao Zhu, Wei Chen & Fengcai Zhu. (2022) Heterologous AD5-nCOV plus CoronaVac versus homologous CoronaVac vaccination: a randomized phase 4 trial. Nature Medicine 28:2, pages 401-409.
Crossref
Crossref
Fatemeh Namazi, Saba Davoodi & Azam Bolhassani. (2022) Comparison of the Efficacy of HIV-1 Nef-Tat-Gp160-p24 Polyepitope
Vaccine Candidate with Nef Protein in Different Immunization Strategies. Current Drug Delivery 19:1, pages 142-156.
Crossref
Crossref
Barbara Ensoli, Sonia Moretti, Alessandra Borsetti, Maria Teresa Maggiorella, Stefano Buttò, Orietta Picconi, Antonella Tripiciano, Cecilia Sgadari, Paolo Monini & Aurelio Cafaro. (2021) New insights into pathogenesis point to HIV-1 Tat as a key vaccine target. Archives of Virology 166:11, pages 2955-2974.
Crossref
Crossref
Anna Hargrave, Abu Salim Mustafa, Asma Hanif, Javed H. Tunio & Shumaila Nida M. Hanif. (2021) Current Status of HIV-1 Vaccines. Vaccines 9:9, pages 1026.
Crossref
Crossref
Jérôme Barrière, Daniel Re, Frédéric Peyrade & Michel Carles. (2021) Current perspectives for SARS-CoV-2 vaccination efficacy improvement in patients with active treatment against cancer. European Journal of Cancer 154, pages 66-72.
Crossref
Crossref
Qian He, Qunying Mao, Jialu Zhang, Lianlian Bian, Fan Gao, Junzhi Wang, Miao Xu & Zhenglun Liang. (2021) COVID-19 Vaccines: Current Understanding on Immunogenicity, Safety, and Further Considerations. Frontiers in Immunology 12.
Crossref
Crossref
Christopher P Karch, Peter Burkhard, Gary R Matyas & Zoltan Beck. (2021) The diversity of HIV-1 fights against vaccine efficacy: how self-assembling protein nanoparticle technology may fight back. Nanomedicine 16:8, pages 673-680.
Crossref
Crossref
Jean-Louis Excler, Melanie Saville, Seth Berkley & Jerome H. Kim. (2021) Vaccine development for emerging infectious diseases. Nature Medicine 27:4, pages 591-600.
Crossref
Crossref
Giulietta Maruggi, Jeffrey B. Ulmer, Rino Rappuoli & Dong Yu. 2022. mRNA Vaccines. mRNA Vaccines
31
70
.
Lindsey R Baden, Daniel J Stieh, Michal Sarnecki, Stephen R Walsh, Georgia D Tomaras, James G Kublin, M Juliana McElrath, Galit Alter, Guido Ferrari, David Montefiori, Philipp Mann, Steven Nijs, Katleen Callewaert, Paul Goepfert, Srilatha Edupuganti, Etienne Karita, Johannes P Langedijk, Frank Wegmann, Lawrence Corey, Maria G Pau, Dan H Barouch, Hanneke Schuitemaker, Frank Tomaka, Julie A. Ake, Susan Buchbinder, Karen Buleza, Kristen W. Cohen, Trevor A. Crowell, Zelda Euler, Ian Frank, Dimitri Goedhart, Michael Keefer, Colleen Kelly, Ken Mayer, Joseph Nkolola, Lauren Peter, Merlin L. Robb, Nadine Rouphael, Lorenz Scheppler, Magda Sobieszczyk & Hong Van Tieu. (2020) Safety and immunogenicity of two heterologous HIV vaccine regimens in healthy, HIV-uninfected adults (TRAVERSE): a randomised, parallel-group, placebo-controlled, double-blind, phase 1/2a study. The Lancet HIV 7:10, pages e688-e698.
Crossref
Crossref
P.J. Klasse, Gabriel Ozorowski, Rogier W. Sanders & John P. Moore. (2020) Env Exceptionalism: Why Are HIV-1 Env Glycoproteins Atypical Immunogens?. Cell Host & Microbe 27:4, pages 507-518.
Crossref
Crossref